Upregulation of thymidylate synthase induces pemetrexed resistance in malignant pleural mesothelioma

The research group of Dr.Hideki Makinoshima of National Cancer Center Tsuruoka Metabolomics Laboratory in collaboration with Shonai Industrial Promotion Center and IAB, published the findings of a new study entitled "Upregulation of thymidylate synthase induces pemetrexed resistance in malignant pleural mesothelioma " in Frontiers in Pharmacology on September 27, 2021.

LINK